Health and Health Commission sent a letter! Promote the introduction of medical insurance for drugs for children's hematology and malignant tumors.

Children's hematology, malignant tumors due to many kinds of diseases, treatment difficult, some of the treatment process involves a number of disciplines or medical institutions, resulting in long treatment cycle, high medical costs, low reimbursement ratio, heavy burden on the family. Recently, the National Health and Health Administration and other five departments issued the "On the development of children's blood diseases, malignant tumor medical treatment and security management of the notice" (National Health Medical Development (2019) No. 50), according to the voluntary principle of patients, for the blood diseases, malignant tumors of children to provide corresponding protection.Health And Wellness Commission official website screenshot
the first batch of selected diseases for 10 species.
, in accordance with the principles of relatively high incidence, clear diagnosis and treatment, heavy economic burden, and other non-tumor children's blood diseases such as
regenerative anemia, immune platelet reduction, haemophilia, haemopha syndrome
, as well as
lymphoma, neuroblastoma, bone and soft tissue sarcoma, hepatoblastoma, nematoma, retinoblastoma and other children'
s physical diseases as the first batch of treatment. On this basis, combined with the technological progress of medical technology and the improvement of the level of protection, the scope of diseases will be gradually expanded, the notice said.
nine measures to protect the treatment of 10 major diseases
(1) to establish and improve the fixed-point hospital and consultation collaboration network.
for non-tumor children's blood diseases, establish and improve the network of diagnostic and treatment services, identify fixed-point hospitals, the implementation of provincial and municipal units of centralized treatment management.
for children's solid tumors, at the provincial level (or conditional city) as a unit, the children's specialized hospital led the formation of cross-medical institutions of the consultation and consultation collaboration group, coordination of the group members to jointly implement physical tumor children chemotherapy, surgery, radiotherapy and other multidisciplinary collaborative diagnosis and treatment.
(2) to improve the standardization of diagnosis and treatment.
to the relevant diagnosis and treatment technical norms, clinical path to ease, find gaps, carry out the revision of the system, and increase the intensity of training.
(3) strengthen the whole process management.
, on the basis of the established and operational registration management system for childhood leukemia diagnosis and treatment in China, improve the project to increase the registration of information on cases of children's haematoma and malignant tumors. Strengthen case tracking management, promote the interconnection of medical information among all kinds of relevant medical institutions, and provide full service. Implementation of family doctorcontract management, guidance to do a good job in treatment organizations, regular review, to provide home, community infection prevention and control, health guidance and other services, publicity and guidance of orderly graded diagnosis and treatment.
(4) to improve the rate of early diagnosis and treatment.In view of the difficult characteristics of early detection of physical tumors in children, the
develops the early screening program for the relevant diseases, defines the appropriate screening indicators and projects, and carries out appropriate technical promotion to demonstrate the implementation during the physical examination of newborns and infants. Increase popular science publicity efforts to guide parents to observe the growth and development of children and physical changes, improve the sensitivity of related symptoms, signs, guide timely medical treatment.
(5) strengthen the security of the supply of medicines.
encourage the research and development and production of new drugs, speed up the domestic approval and listing of new drugs listed abroad, encourage the research and development of clinically urgentdrugs, and implement priority review and approval of eligible anti-cancer drugs and children's drugs. Explore the use of surplus plasma in blood stations to produce blood products for the treatment of children with blood diseases and malignant tumors.
(6) implement the comprehensive medical security policy.
to subsidize qualified people in need to participate in basic medical insurance, speed up the establishment of a unified basic medical insurance system for urban and rural residents, increase the insurance guarantee capacity for major diseases, enhance the guarantee capacity of medical assistance, realize the effective convergence of the three systems, give full play to the benefits of comprehensive protection, and jointly reduce the burden of patient expenses.
(7) to push forward health care payment reform.
improve the dynamic adjustment mechanism of the medical insurance drug catalogue, and gradually bring more eligible children's blood diseases, malignant tumors and other major diseases treatment drugs into the scope of medical insurance payment. We will further promote the reform of the payment method of medical insurance, and guide all localities to give priority to the implementation of pay-per-disease for diseases with clear treatment options, and reasonably measure the standard of payment for diseases.
(8) simplify the procedure for reimbursement of referrals.
in response to the need for children with physical tumors to seek medical treatment in multiple medical institutions, the medical insurance department simplifies the procedures for filing direct settlement and referral for medical treatment in different places, accelerates the promotion of telephone, fax, network, APP and other filing and inquiry methods, optimizes the manual reimbursement process, and pays the medical insurance fund in a timely manner.
(9) strengthen the
of social assistance and charitable assistance. Children and families with special difficulties who meet the conditions of social assistance shall be provided with timely and in accordance with the provisions. We will raise the awareness of the whole society on children's hematology and malignant tumors, and further encourage and guide charitable forces to participate in the medical treatment and life assistance of related diseases.
attached to the original text: "Notice on the medical treatment and protection of children's blood diseases and malignant tumors"

.